| Literature DB >> 34927172 |
Jingjing Jiao1, Lanjing Zhang1,2,3,4.
Abstract
BACKGROUND ANDEntities:
Keywords: Duodenal ulcer; Gastric ulcer; Liver penetration; Peptic hepatitis
Year: 2021 PMID: 34927172 PMCID: PMC8681229 DOI: 10.14218/jctp.2021.00007
Source DB: PubMed Journal: J Clin Transl Pathol
Fig. 1.Study flow diagram.
Fig. 2.Distribution of patients’ age for: (a) duodenal ulcer; and (b) and gastric ulcer separated by gender.
p-value: comparison between male and female patients by Student t-test.
Fig. 3.Anatomical location of: (a) perforated duodenal ulcer; and (b) and gastric ulcer.
Clinical and demographic features of duodenal and gastric ulcers with liver perforation or penetration. Data presented as median (quartile)
| Duodenal ulcer (n = 20) | Gastric ulcer (n = 22) | ||
|---|---|---|---|
|
| |||
| Age (years) | 64.5 (54–81) | 65.5 (53–73.5) | 0.64 |
| Ulcer histology | |||
| Malignant/total | 0/11 | 2/12 (16.7%) | 0.48 |
| Gender | |||
| Female/total | 8/20 (40%) | 7/21 (33.3%) | 0.66 |
| Region | 0.68 | ||
| Asia | 8 (40%) | 7 (31.8%) | |
| Europe | 6 (30%) | 11 (50%) | |
| America | 5 (25%) | 3 (13.6%) | |
| Other | 1 (5%) | 1 (4.5%) | |
| History of NSAIDs use (n = 15) | 0.99 | ||
| yes | 5 (50%) | 2 (40%) | |
| no | 5 (50%) | 3 (60%) | |
| 0.99 | |||
| positive | 4 (66.7%) | 3 (75%) | |
| negative | 2 (33.3%) | 1 (25%) | |
| Possible history of PUD (n = 19) | 0.14 | ||
| yes | 1 (16.7%) | 8 (61.5%) | |
| no | 5 (83.3%) | 5 (38.5%) | |
| Size of ulcer (largest dimension cm) (n = 18) | 2.5 (1.38–3.20) | 4.75 (3.25–5.75) | 0.01 |
| Mortality (n = 32) | 0.66 | ||
| dead | 2 (13.3%) | 4 (23.5%) | |
| alive | 13 (86.75) | 13 (76.5%) | |
| Follow-up (days) | 63 (41.25–225) | 90 (54–570) | 0.73 |
NSAIDs, non-steroidal anti-inflammatory drugs.
Fig. 4.Representative images of biopsy samples from a duodenal ulcer penetration that involved the liver by Hematoxylin & Eosin staining: (a) 200 ×; (b) 40 ×; (c) immunohistochemistry of CK7; (d) arginase; and (e) and CK8/18.
Biopsy samples showed hepatocyte with: (a) atypia, steatotic change, and inflammation; (b) infiltrating glands; (c) atypical epithelium was positive for CK7 and had a lobular configuration in low-power view (arrows); (d) involved liver parenchyma was positive for arginase (arrowheads); and (e) positive staining in CK8/18 suggestive of a biliary origin and CK8/18 might be confused with hepatoid carcinoma. The presence of biliary epithelium negated the possibility of a hepatoid carcinoma.
Diagnostic pearls for differential diagnosis of peptic ulcer with liver perforation or penetration versus hepatocellular carcinoma and hepatoid adenocarcinoma
| Peptic ulcer that involves liver | Hepatoid adenocarcinoma | Hepatocellular carcinoma, metastatic | |
|---|---|---|---|
|
| |||
| Cytology | Biphasic atypical cells including reactive hepatocytes and bile ducts | Large, atypical cells with abundant eosinophilic cytoplasm (cytoplasmic glycogen and hyaline globules) | Similar to that in hepatoid adenocarcinoma |
| Histology | Lobular configuration of the atypical glands (bile ducts), and atypical large polygonal cells (hepatocytes); no bona fide single cells | Lack of small glands with cuboidal epithelium (bile ducts); infiltrative pattern; single cells may present | Similar to that in hepatoid adenocarcinoma |
| Immunohistochemistry | |||
| positive | Hepatocytes are positive for | Positive for CDX-2, | Positive for CK8/18, |
| Immunohistochemistry | |||
| negative | Bile ducts are negative for arginase, HepPar1 and TTF-1 (cytoplasm) while hepatocytes are negative for CK7 | Negative for CK7 | Negative for CDX-2, |
AFP, alpha-fetal protein; CK, cytokeratin; TTF-1, Thyroid transcription factor-1; CDX-2, Caudal Type Homeobox 2; CEA, carcinoembryonic antigen.